//
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
A population-based study of 92 clinically recognised risk factors for heart failure: co-occurrence, prognosis and preventive potential
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction